![Christiaan L. J. J. Stijnen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Christiaan L. J. J. Stijnen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christiaan L. J. J. Stijnen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Bocconi | College/University | Masters Business Admin Masters Business Admin | |
University of Oxford | College/University | Doctorate Degree | |
Université Paris-Saclay | College/University | Doctorate Degree | |
Aetna Partners GmbH
![]() Aetna Partners GmbH Investment ManagersFinance Aetna Partners GmbH provides investment services. It offers a small circle of private investors with a long term investment horizon and an entrepreneurial background the possibility to transact direct investments in real assets with growth potential. The company was founded by Hans C. Bodmer, Thomaz Burckhardt and Felix Werthemann and is headquartered in Zurich, Switzerland. | Investment Managers | Founder | |
Malaria Consortium
![]() Malaria Consortium Medical/Nursing ServicesHealth Services Malaria Consortium is a non-profit organization that specializes in preventing, controlling, and treating malaria and other communicable diseases among vulnerable populations. The non-profit company is based in London, UK. Malaria Consortium's evidence-based programs combat targeted diseases and promote universal health coverage in Africa and Asia. The British company was founded in 2003 by Sylvia Meek, and the CEO is Charles Nelson. | Medical/Nursing Services | Director/Board Member | |
Atlantic Healthcare Plc
![]() Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Mumbai | College/University | Doctorate Degree | |
INSEAD | College/University | Masters Business Admin | |
DMS IMAGING | Biotechnology | Chief Tech/Sci/R&D Officer | |
The New York Intellectual Property Law Associations
![]() The New York Intellectual Property Law Associations Miscellaneous Commercial ServicesCommercial Services The New York Intellectual Property Law Associations operates as professional association composed primarily of experienced lawyers interested in intellectual property law. The company was founded on March 7, 1922 and is headquartered in Fort Lee, NJ. | Miscellaneous Commercial Services | President | |
Hughes Hubbard & Reed LLP
![]() Hughes Hubbard & Reed LLP Miscellaneous Commercial ServicesCommercial Services Hughes Hubbard & Reed LLP is engaged in the provision of legal services. Its services include corporate governance, merger and acquisition, capital markets, private equity, equipment finance & banking legal services. The company was founded by Charles Evan Hughes in 1884 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Princeton University | College/University | Doctorate Degree | |
Columbia Law School | College/University | Graduate Degree | |
Xavier University of Louisiana | College/University | Undergraduate Degree | |
New York Intellectual Property Law Education Foundation | Corporate Officer/Principal | ||
Dellmed Consulting | Founder | ||
Les Laboratoires Servier SAS
![]() Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Leiras
![]() Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
University of Helsinki | College/University | Doctorate Degree | |
Aalto University School of Business | College/University | Masters Business Admin | |
SAVARA INC. | Pharmaceuticals: Major | President | |
Mirror Biologics Inc
![]() Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | Biotechnology | Director/Board Member | |
APR Applied Pharma Research SA
![]() APR Applied Pharma Research SA BiotechnologyHealth Technology APR Applied Pharma Research SA develops and licenses healthcare products and technologies. It specializes in the development of oral and topical formulations in various healthcare regulatory areas ranging from Rx and OTC pharmaceuticals, nutraceuticals, dermocosmetics, and medical devices. The company was founded in 1990 and is headquartered in Balerna, Switzerland. | Biotechnology | Chief Executive Officer | |
Institute For Pharmacokinetic & Analytical Studies | Chief Executive Officer | ||
Farma Resa Imp SRL
![]() Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Part of Pierrel SpA, Farma Resa Imp SRL is an Italian company that specializes in the preparation of pharmaceutical tests. The company is based in Cantu, Italy. Farma Resa Imp was acquired by Pierrel Research Italy SpA on September 30, 2010 for $2.14 million. | Pharmaceuticals: Major | Chief Executive Officer | |
Anergis SA
![]() Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Merck Serono SA
![]() Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal | |
Rhone Poulenc Rorer
![]() Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
Università degli Studi di Napoli Federico II | College/University | Graduate Degree |
Statistics
International
United States | 11 |
Switzerland | 8 |
France | 6 |
Finland | 5 |
Italy | 4 |
Sectoral
Health Technology | 17 |
Consumer Services | 12 |
Commercial Services | 3 |
Finance | 2 |
Health Services | 2 |
Operational
Corporate Officer/Principal | 16 |
Director/Board Member | 9 |
Chief Executive Officer | 5 |
Doctorate Degree | 5 |
Chief Operating Officer | 4 |
Most connected contacts
Insiders | |
---|---|
Taneli Jouhikainen | 11 |
Gilles Della Corte | 10 |
Nermeen Varawalla | 7 |
Patrice Jean | 7 |
Paolo Galfetti | 5 |
Marco Marotta | 3 |
Thomaz Burckhardt | 2 |
- Stock Market
- Insiders
- Christiaan L. J. J. Stijnen
- Company connections